EMERGENT BIOSOLUTIONS INC. Fair Value of Long-Term Debt
EMERGENT BIOSOLUTIONS INC. (EBS) had Fair Value of Long-Term Debt of $62.80 million as of 2012-12-31, per its 10-K filed 2013-03-08.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2013-03-08
- 2012-12-31: Long-term Debt, Fair Value $62.80M.
- 2012-09-30: Long-term Debt, Fair Value $63.01M.
- 2012-06-30: Long-term Debt, Fair Value $62.20M.
- 2011-12-31: Long-term Debt, Fair Value $59.50M.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2012-12-31 | $62.80M 10-K · filed 2013-03-08 |
| 2012-09-30 | $63.01M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $62.20M 10-Q · filed 2012-08-03 |
| 2011-12-31 | $59.50M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |